Live cell therapywhy its not about healing and performing miracles

EDENKOBEN, a postcard-pretty town an hours drive south of Frankfurt, offers picturesque scenes of vineyards

Its not only about adding years to life, but adding life to years.

This in essence sums up the philosophy behind Dr. Robert Janson-Mllers practice as a general practitioner in Munich and as a specialist (one of a handful) in live cell therapy in Edenkoben, a picturesque, grape-producing town one hour south of Frankfurt.

A growing number of Asians, including Filipinos suffering from such ailments as diabetes, heart disease, degenerative disorders of the joints and spinal column, multiple sclerosis, mild depression, burnout, migraine and even impotence, are braving the 14-hour flight to Germany to avail themselves of the therapy pioneered in the 30s by Swiss doctor Paul Niehans.

Live cell therapy, which is an organ-specific approach, involves harvesting fresh cells from sheep embryo and injecting them directly (intramuscular) on the patients buttocks.

Not a few parents also swear by the therapys beneficial effects on their children with mild autism, attention deficit and hyperactivity disorder (ADHD) and Downs syndrome.

DR. ROBERT Janson-Mller and his team composed of Joesoef Agoes, head nurse Simone Huethere, Dr.Wolgang Janson-Mller, assistant nurse Debbie Lehmann and Joey Santos

Better functions

During our coverage, for instance, we came across an Indonesian couple with an 11-year-old son with ADHD and mild autism. After trying all sorts of treatments to improve their sons focus and EQ, including a daily dose of the drug Concerta, the couple learned about live cell therapy from another parent with an autistic son.

Before live cell therapy, he was mostly limited to one-word sentences, said the dad of his son. And when he talked to people, he lacked eye contact. Now, I could teach him to form complete thoughts and sentences.

See the original post here:
Live cell therapywhy its not about healing and performing miracles

Related Posts

Comments are closed.